Puncture in Medical News
Navigation Links
Puncture in Medical News
Biogel Introduces Polyisoprene (PI) Indicator Underglove
... PI surgical gloves to form a synthetic, patented puncture indication system. The double-glove puncture indication system provides an immediate visual ... of fluid. Biogel's existing Patented puncture Indicator System, using latex gloves, alerts ...Spinal taps carry higher risks for infants and elderly, study shows
... by the procedure can be reduced by doing the puncture at the middle of the lower back rather than at ... this procedure." Fluoroscopy-guided lumbar puncture is used most often to diagnose patients who have ... All had received a fluoroscopy-guided lumbar puncture in emergency room, outpatient or inpatient ...Most babies with uncomplicated febrile seizures can avoid spinal tap
... where their workup frequently includes a lumbar puncture (spinal tap) to rule out bacterial meningitis. ... call on physicians to consider doing a lumbar puncture in children 12 to 18 months old with a first ... febrile seizure and to "strongly" consider lumbar puncture for infants 6 to 12 months old. But when Amir and ...Barefoot Lifestyle Has Its Dangers
... shoes and socks suffer injuries such as cuts and puncture wounds. In some cases, those injuries develop ... may not "feel" a foot injury. If you suffer a puncture wound in your foot, see a doctor within 24 hours. A puncture wound must be cleaned properly and monitored ...... thousands will suffer injuries such as cuts and puncture wounds. Some will develop nasty infections that ... a foot and ankle surgeon within 24 hours for a puncture wound. Why: These injuries can embed unsterile foreign objects deep inside the foot. A puncture wound must be cleaned properly and monitored ...
ExoSeal vascular plug gets good reviews in ECLIPSE study
... A new bioabsorbable plug that seals the arterial puncture site used for threading catheters into the body ... acid. It is anchored in place on top of the puncture in the femoral artery, after the catheter is ... the devices applicability in patients with access puncture sites at or below the branchpoint of the femoral ...... two primary methods to close the femoral artery puncture site: direct manual compression over the puncture site or one of the various implantable vascular ... or staples) to create a physical seal of the puncture site. "The Catalyst II device promises to build ...
... two primary methods to close the femoral artery puncture site: direct manual compression over the puncture site or one of the various implantable vascular ... staples) to create a physical seal of the puncture site. There are considerable drawbacks to ...
... two primary methods to close the femoral artery puncture site: direct manual compression over the puncture site or one of the various implantable vascular ... staples) to create a physical seal of the puncture site. There are considerable drawbacks to ...
... abortions -- can have devastating health effects, including uterine puncture or rupture, puncture of the uterine artery, permanent injury to the cervix, and risks for ...
... intended for use with a biological sealant to seal the femoral arterial puncture site following diagnostic or interventional catheterization procedures. ... closure system (VCS) that is intended to seal the femoral arterial puncture site following diagnostic or interventional catheterization procedures. ...
Large study identifies most costly adverse events in children's hospitals
... of hospital stay from PDI events ranged from 2.8 days for accidental puncture and laceration to 23.5 days for postoperative sepsis. Excess overall charges ranged from $34,884 for accidental puncture and laceration to $337,226 for in-hospital mortality after pediatric heart ...National Quality Forum Endorses Consensus Standards for Quality of Hospital Care
... average length of stay-deliveries Patient Safety, Adult -- Accidental puncture or laceration -- Death in low mortality DRGs -- Iatrogenic ... age 18 years and older Patient Safety, Pediatrics -- Accidental puncture or laceration -- Decubitus ulcer -- Iatrogenic pneumothorax in ...Researchers find relief for chronic pain
... new study Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain published in the January 22, 2008 issue of the ... as morphine. Based on our findings, this targeted gene therapy via lumbar puncture appears to be a promising candidate for bench-to-bedside research that ...... cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets. The company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...
Kenneth Kensey, Inventor of the Angio-Seal(R), Dies at 58
... Corporation in 1984, where he was responsible for creating numerous new medical technologies including the Angio-Seal(R), the leading femoral artery puncture closure device marketed by St. Jude Medical, as well as the Kensey Catheter for Dynamic Angioplasty. Dr. Kensey's devices are in use worldwide. His ...Pennsylvania Patient Safety Authority Releases June Advisory
... The Authority has received 376 reports of complications that occur during certain gynecologic procedures. The most commonly reported event is the puncture of organs (77%), most frequently the uterus (96%). This article details the information found in the data and gives risk reduction strategies for ...... require only a single blood draw from the patient, which is significantly less invasive than tests requiring cerebrospinal fluid obtained by lumbar puncture (spinal tap) and quicker and cheaper than repeated imaging techniques (MRI). Cytox's blood biomarkers have been validated for use in FDA trials ...
ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark
... Licensing Agreement and a Development and Regulatory Services Agreement. The Company is known as a pioneer in the field of biomaterials and arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. About ...
Kensey Nash Corporation Adopts Stockholder Rights Plan
... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...Abbott Announces Launch of Next-Generation Embolic Protection System
... treatment option. During a carotid stenting procedure, an embolic protection system and stent are deployed using a catheter inserted into a small puncture in an artery in the patient's groin area. The patient usually remains conscious while the stent is implanted at the site of the blockage. The stent ...Kensey Nash to Present at the Jefferies 3rd Annual Healthcare Conference
... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)
... initially with 6-9Fr applications. The MedClose(TM) VCS device consists of two parts; (1) A delivery system that delivers the sealant to the puncture site, and, (2) the synthetic sealant itself. While we will continue to refine the MedClose(TM) VCS device commercially, we have already reached the ...Kensey Nash to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...Product Stewardship Institute Announces Two New Sustaining Partners
... and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Company also offers a number of products specifically designed for the home healthcare market and ...Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
... to manufacture and develop these products for Spectranetics for a period of time. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...Study: Every 1.7 minutes a Medicare beneficiary experiences a patient safety event
... failure Post-operative pulmonary embolism or deep vein thrombosis Post-operative sepsis Post-operative abdominal wound dehiscence Accidental puncture or laceration Transfusion reaction ...New Device Treats Common Heart Rhythm Disorder
... a leg vein to guide the device into the heart; the device travels through the heart's right chamber and is deposited into the left atrium through a puncture hole between the two chambers of the heart, the researchers explained. Current treatment with warfarin is effective in preventing strokes caused ...Kensey Nash Announces 600,000 Share Stock Repurchase Program
... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...Glass tables: An overlooked safety threat
... MD, of the Division of Emergency Medicine at Children's Hospital Boston, who led the study. Last December, a Rhode Island girl died from a severe puncture wound to her leg. After earlier media reports about children seen at Children's Hospital Boston with severe lacerations, Consumers Union collaborated ...Penn Medicine pathologists pioneer biomarker test to diagnose or rule out Alzheimer's disease
... the Penn Alzheimer's Disease Core Center and at ADNI trial sites around the US and Canada, we have validated a test where a safe, simple lumbar puncture can provide information to confirm suspected Alzheimer's disease and predict the onset of the disease," said John Q. Trojanowski, MD, PhD, Director ...... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...
... commercialization strategy for MedClose(TM). MedClose(TM) is an investigational-stage vascular closure system that is intended to seal arterial puncture sites following diagnostic or interventional catheterization procedures. CPC will develop synthetic PEG sealants as platform technologies for ...
Kensey Nash Announces Appointment of Chief Financial Officer
... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results
... and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Sharps(R)MWMS(TM), a Medical Waste Management System, is a comprehensive medical waste ...Kensey Nash Announces Director Resignation
... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...Sharps Compliance Announces $40 Million U. S. Government Contract
... and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Company also offers a number of products specifically designed for the home healthcare market ...Most support Alzheimer's research based on family consent
... Institute on Aging. The participants answered questions regarding one of four randomly assigned surrogate-based research scenarios: lumbar puncture study, a drug randomized control study, a vaccine study and a gene transfer study. Each participant answered three questions: whether our society ...Other ContentsbowlegsretrainingretrainingbracebracebracebracebradycardiabradycardiaplexopathyaneurysmaneurysmaneurysmOther TagsAssociateAssociateAssociateAssociateULTRAMERDOVERMidstreamCURITYCURITYBladderScan
(Date:12/16/2009)... superstitions and rituals can help them get psyched up ... drugs (NSAIDs), which many athletes gobble down before and ... good. , "These agents are treatments for the symptoms ... Warden, whose research at Indiana University focuses on musculoskeletal ... to exercise or train at a certain level, but ...
(Date:12/16/2009)... YORK, Dec. 1 iQor, a global provider ... the 2009 InfoWorld 100 Awards Top 100 ... TeQ21. This was the first submission for iQor. ,, ... list of companies," said Vikas Kapoor, president and CEO ... do business, allowing us to work faster, smarter and ...
(Date:12/16/2009)... -- IgeaCare Solutions Inc. is pleased to announce ... communications company previously operating as IgeaCare Systems Inc. ... forward under new leadership and funding. ,, IgeaCare ... the position of Chief Executive Officer. Under his ... a superior servicing and support model; fast and ...
Breaking Biology News(10 mins):NSAIDs: Take 'em early and often when competing? Think again 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 1Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 2Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 3September October 2009 Annals of Family Medicine tip sheet 57891 1September October 2009 Annals of Family Medicine tip sheet 57891 2September October 2009 Annals of Family Medicine tip sheet 57891 3September October 2009 Annals of Family Medicine tip sheet 57891 4September October 2009 Annals of Family Medicine tip sheet 57891 5September October 2009 Annals of Family Medicine tip sheet 57891 6Toxin detection as close as an inkjet printer 14194 1Toxin detection as close as an inkjet printer 14194 2(Date:12/16/2009)... of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 million ... included in the final Fiscal Year 2010 Defense Appropriations ... research cancers, like colorectal cancer, that are not addressed ... programs run by the U.S. Army Medical Research and ... funding for this new cancer research program was included ...
(Date:12/16/2009)... is long-term goal, researchers say , , WEDNESDAY, Dec. ... to predict whether a patient will suffer a second ... "This is an important new tool because studies have ... after a first stroke are more likely to die ... General Hospital and Harvard Medical School, said in an ...
(Date:12/16/2009)... plays a role in reducing inflammation in the lungs ... variant that plays a role in inflammation seems to ... as adults who smoke. , Researchers also found that ... had a lower risk of developing chronic obstructive pulmonary ... smoking. , "The gene seems to be protective of ...
(Date:12/16/2009)... health and environmental concerns about the emerging nanotechnology industry, ... behavior of nanoparticles in municipal sewage treatment plants ... published in ACS, journal Environmental Science & Technology ... Ecology and Hydrology and colleagues note that experts predict ... less than 1/1000th the width of a human hair ...
(Date:12/16/2009)... commonly found in fatty fish and algae help ... by the American Psychological Association. The finding connects ... people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit hyperactivity ... nervous system. , The study, reported in ... evidence that fish is brain food. The key ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:Behavior modification could ease concerns about nanoparticles 2Health News:New study links DHA type of omega-3 to better nervous-system function 2CareSuiteErecAidOsbonAssociateCryostarEftiarRobinsonULTRAMERKENGUARDDOVERMidstreamCURITYCommodeBladderScan
Other Tagstool 2tool 3tool 4tool 5tool 6tool 7tool 8tool 9tool 10incidence 2incidence 3incidence 4incidence 5incidence 6incidence 7incidence 8incidence 9incidence 10differ 2differ 3differ 4differ 5differ 6differ 7differ 8differ 9going 2going 3going 4going 5going 6going 7going 8going 9going 10enters 2enters 3happens 2happens 3happens 4happens 5happens 6happens 7happens 8happens 9happens 10activity 2activity 3activity 4activity 5activity 6activity 7activity 8activity 9activity 10ordinary 2training 2training 3training 4training 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |